Urgent in the World
Breaking news, corroborated before it is published
About
← All stories
DEVELOPING — SINGLE SOURCE, NOT YET CORROBORATED
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
02 Oct 2026, 15:20 UTC · 1 source
Share:
Share…
WhatsApp
X
Email
Sources
CNBC
Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s